Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Matsuo

Showing results (1-10 of 307) with videos related to

Pageof 31
Sort By:
Brain & Development|November 15, 2011
Challenges of supplementary treatment for neurodegenerative diseasesMasafumi Matsuo
No to Hattatsu = Brain and Development|June 13, 2009
[Frontline studies on Duchenne muscular dystrophy treatment]Masafumi Matsuo
JMA Journal|August 20, 2021
Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular DystrophyMasafumi Matsuo
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Muscle diseases, especially on Duchenne muscular dystrophy]Masafumi Matsuo
International Journal of Molecular Sciences|February 13, 2025
30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon SkippingMasafumi Matsuo
IUBMB Life|July 10, 2002
Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapyMasafumi Matsuo
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 25, 2009
[Mutation-specific treatments for Duchenne muscular dystrophy]Masafumi Matsuo, Yasuhiro Takeshima
No to Hattatsu = Brain and Development|June 16, 2006
[Updates in muscular dystrophy research: from pathogenesis to therapeutic strategy]Masafumi Matsuo, Shinji Takeda
No to Hattatsu = Brain and Development|April 18, 2014
[Therapeutic strategies for muscular dystrophy: F based on the international guideline]Masafumi Matsuo, Ikuya Nonaka
Tropical Medicine & International Health : TM & IH|July 9, 2002
Association of a missense mutation of the laminin alpha2 gene with tuberculoid type of leprosy in Indonesian patientsTri Wibawa, Hardyanto Soebono, Masafumi Matsuo
Pageof 31

Showing results (1-10 of 307) with videos related to

Sort By:
Pageof 31
Brain & Development|November 15, 2011
Challenges of supplementary treatment for neurodegenerative diseasesMasafumi Matsuo
No to Hattatsu = Brain and Development|June 13, 2009
[Frontline studies on Duchenne muscular dystrophy treatment]Masafumi Matsuo
JMA Journal|August 20, 2021
Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular DystrophyMasafumi Matsuo
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[Muscle diseases, especially on Duchenne muscular dystrophy]Masafumi Matsuo
International Journal of Molecular Sciences|February 13, 2025
30 Years Since the Proposal of Exon Skipping Therapy for Duchenne Muscular Dystrophy and the Future of Pseudoexon SkippingMasafumi Matsuo
IUBMB Life|July 10, 2002
Duchenne and Becker muscular dystrophy: from gene diagnosis to molecular therapyMasafumi Matsuo
Brain and Nerve = Shinkei Kenkyu No Shinpo|August 25, 2009
[Mutation-specific treatments for Duchenne muscular dystrophy]Masafumi Matsuo, Yasuhiro Takeshima
No to Hattatsu = Brain and Development|June 16, 2006
[Updates in muscular dystrophy research: from pathogenesis to therapeutic strategy]Masafumi Matsuo, Shinji Takeda
No to Hattatsu = Brain and Development|April 18, 2014
[Therapeutic strategies for muscular dystrophy: F based on the international guideline]Masafumi Matsuo, Ikuya Nonaka
Tropical Medicine & International Health : TM & IH|July 9, 2002
Association of a missense mutation of the laminin alpha2 gene with tuberculoid type of leprosy in Indonesian patientsTri Wibawa, Hardyanto Soebono, Masafumi Matsuo
Pageof 31